(H4ZP) HSBC MSCI China - Ratings and Ratios

The HSBC MSCI China UCITS ETF (XETRA:H4ZP) is an exchange-traded fund that tracks the Morningstar China TME NR USD index, providing investors with exposure to the Chinese equity market. As a Germany-domiciled ETF, it is listed on the XETRA exchange and falls under the China Equity category.

From a technical analysis perspective, the ETFs price is currently at €6.42, slightly below its 20-day simple moving average (SMA) of €6.51, indicating a potential short-term downtrend. However, its 50-day SMA is at €6.42, and the 200-day SMA is at €6.32, suggesting a longer-term uptrend. The average true range (ATR) is €0.09, representing a 1.44% daily price movement, indicating moderate volatility. The ETFs 52-week high and low are €7.33 and €4.90, respectively, showing a significant range of price movements over the past year.

With assets under management (AUM) of €769.81 million, the HSBC MSCI China UCITS ETF has a substantial presence in the market, indicating a reasonable level of liquidity. As the fund tracks the Morningstar China TME NR USD index, its performance is closely tied to the overall Chinese equity market.

Based on the available technical and fundamental data, a forecast for the HSBC MSCI China UCITS ETF can be made. Considering the ETFs current price is near its 50-day SMA and above its 200-day SMA, it may be poised for a potential rebound. If the Chinese equity market continues to grow, the ETFs AUM is likely to increase, potentially driving the price higher. However, if the market experiences a downturn, the ETFs price may decline. A potential target price could be €7.00, representing a 9% increase from the current price, assuming the Chinese equity market continues to grow and the ETFs AUM remains stable or increases.